Stocksigma LogoStocksigma Logo

Gland Pharma Issues €20 Mn Corporate Guarantee for Subsidiary Phixen SAS

Gland Pharma Limited has issued a corporate guarantee of €20 Mn in favor of MUFG Bank (Europe) N.V. on behalf of its wholly owned step-down subsidiary

Gland Pharma Issues €20 Mn Corporate Guarantee for Subsidiary Phixen SAS

Gland Pharma Ltd · Others (Uncategorized) · 12 Nov 2026, 10:49 pm

Gland Pharma Issues €20 Mn Corporate Guarantee for Subsidiary Phixen SAS Gland Pharma Limited has issued a corporate guarantee of €20 Mn in favor of MUFG Bank (Europe) N.V. on behalf of its wholly owned step-down subsidiary, Phixen SAS. The guarantee secures an uncommitted revolving facility of €50 Mn (initial drawdown limit of €18 Mn) entered by Phixen SAS. The facility agreement is valid for three years, while the corporate guarantee remains valid until 31st Mar'30 and will be treated as a contingent liability for Gland Pharma. The guarantee limit may expand if future drawdown limits increase.

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements